NuCana (NCNA) Payables (2016 - 2025)

NuCana's (NCNA) quarterly Payables came in at $694346.8 in Q4 2025, down 80.0% year-on-year from $3.5 million in Q4 2024, and down 69.04% quarter-over-quarter from $2.2 million in Q3 2025.

NuCana (NCNA) Payables (2016 - 2025) Analysis & Trends

NuCana has disclosed Payables across 10 years of filings, most recently posting $694346.8 for Q4 2025.

  • Payables for Q4 2025 came in at $694346.8, down 80.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $694346.8 (down 80.0% YoY), and the FY2025 annual result was $688262.4, down 80.09% from the prior year.
  • Payables came in at $694346.8 for Q4 2025 at NuCana, down from $2.2 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $7.9 million in Q3 2024 to a low of $694346.8 in Q4 2025.
  • The 5-year median for Payables is $4.5 million (2021), against an average of $4.5 million.
  • Across the five-year window, Payables jumped 128.5% in 2022 and slumped 81.0% in 2025, its largest moves.
  • NuCana's Payables stood at $2.5 million in 2021, then surged by 128.5% to $5.6 million in 2022, then dropped by 25.64% to $4.2 million in 2023, then fell by 17.12% to $3.5 million in 2024, then slumped by 80.0% to $694346.8 in 2025.
  • The last three Payables figures came in at $694346.8 (Q4 2025), $2.2 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 1.05 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 300,549.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 83.00 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 8.69 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 489.30 Mn
9 Abivax 94.26 Bn 94.26 Bn - 34.55 Mn
10 NuCana 29.13 Bn 29.13 Bn - 694,346.76

Historic Data

Download Data
DateValue
Dec 31, 2025 694,346.76
Sep 30, 2025 2.24 Mn
Jun 30, 2025 1.46 Mn
Mar 31, 2025 3.03 Mn
Dec 31, 2024 3.47 Mn
Sep 30, 2024 7.85 Mn
Jun 30, 2024 7.71 Mn
Mar 31, 2024 7.31 Mn
Dec 31, 2023 4.19 Mn
Sep 30, 2023 6.55 Mn
Jun 30, 2023 5.86 Mn
Mar 31, 2023 6.92 Mn
Dec 31, 2022 5.63 Mn
Sep 30, 2022 6.62 Mn
Jun 30, 2022 2.70 Mn
Mar 31, 2022 3.62 Mn
Dec 31, 2021 2.47 Mn
Sep 30, 2021 5.36 Mn
Jun 30, 2021 2.37 Mn
Mar 31, 2021 4.88 Mn